Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026
Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum